6.6 COMPARING THE EFFECTS OF NEBIVOLOL VERSUS METOPROLOL SUCCINATE ON CENTRAL HAEMODYNAMICS, FUNCTIONAL-STRUCTURAL CHANGES OF ARTERIES, AND LEFT VENTRICULAR WALL THICKNESS: THE NEMENDAS STUDY

6.6 COMPARING THE EFFECTS OF NEBIVOLOL VERSUS METOPROLOL SUCCINATE ON CENTRAL HAEMODYNAMICS, FUNCTIONAL-STRUCTURAL CHANGES OF ARTERIES, AND LEFT VENTRICULAR WALL THICKNESS: THE NEMENDAS STUDY

Bibliographic Details
Main Authors:	M. Serg, P. Kampus, J. Kals, M. Zagura, P. Muda, K. Karu, T.P. Tuomainen, M. Zilmer, J. Eha
Format:	Article
Language:	English
Published:	Atlantis Press 2010-12-01
Series:	Artery Research
Online Access:	https://www.atlantis-press.com/article/125929348/view

Similar Items

P8.12 ASSOCIATION BETWEEN ASYMMETRIC DIMETHYLARGININE AND THE INDICES OF VASCULAR FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION
by: M. Sergejev, et al.
Published: (2009-12-01)

Value of haemodynamic profiling to the response of antihypertensive therapy
by: M. Serg, et al.
Published: (2014-09-01)

P12.06 DOES A 6-MONTH MILITARY MISSION IN AFGHANISTAN HAVE AN IMPACT ON INFLAMMATION MARKERS, VITAMIN D LEVEL, AND ARTERIAL STIFFNESS?
by: E. Salum, et al.
Published: (2010-12-01)

3.6 OSTEOPROTEGERIN IS ASSOCIATED INDEPENDENTLY WITH AORTIC STIFFNESS IN PATIENTS WITH ATHEROSCLEROSIS AND IN HEALTHY SUBJECTS
by: M. Zagura, et al.
Published: (2009-12-01)

P5.14 ARTERIAL STIFFNESS IS ASSOCIATED WITH THE SEVERITY OF ATHEROSCLEROSIS AND SERUM OSTEOPONTIN LEVELS IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE
by: M. Zagura, et al.
Published: (2011-11-01)

P3.06 AORTIC STIFFNESS AND VITAMIN D ARE INDEPENDENT MARKERS OF AORTIC CALCIFICATION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE
by: M. Zagura, et al.
Published: (2010-12-01)

The effect of pre-seasonal strength training on central hemodynamics and cardiac function in elite powerlifting athletes
by: Jürgenson J, et al.
Published: (2019-07-01)

P3.9 METABOLOMIC SIGNATURE OF ARTERIAL STIFFNESS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
by: M. Zagura, et al.
Published: (2014-11-01)

Effect of Half-Marathon Running on Arterial Stiffness and Blood Biomarkers in High-Level and Recreational Male Athletes
by: Janno Jürgenson, Martin Serg, Priit Kampus, Jaak Kals, Maksim Zagura, Kersti Zilmer, Mihkel Zilmer, Jaan Eha, Eve Unt
Published: (2021-12-01)

P4.29 COMPARATIVE EFFECTS OF ANTIHYPERTENSIVE DRUGS ON OXIDATIVE STRESS AND INFLAMMATION
by: M. Serg, et al.
Published: (2013-11-01)

Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
by: Vaidya V, et al.
Published: (2012-02-01)

Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension
by: Huseyin Ugur Yazici, et al.
Published: (2013-01-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

FORMULATION AND IN VITRO EVALUATION OF METOPROLOL SUCCINATE FLOATING TABLETS
by: Sunil Thakral, et al.
Published: (2013-07-01)

Metoprolol succinate extended release/hydrochlorothiazide combination tablets
by: James W Hainer, et al.
Published: (2007-07-01)

Der Einfluss der Betablocker Nebivolol und Metoprolol auf das ischämische akute Nierenversagen
by: Schloßer, Otto Sebastian
Published: (2019)

Metoprolol tartrate and succinate: from chemical structure to clinical effectiveness differences
by: Yu. B. Belousov, et al.
Published: (2007-06-01)

P4.09 BASELINE AUGMENTATION INDEX AND PULSE PRESSURE AMPLIFICATION DETERMINE THE RESPONSE TO ANTIHYPERTENSIVE THERAPY
by: M. Serg, et al.
Published: (2012-11-01)

P48 Effects of Remote Ischaemic Preconditioning on Haemodynamic and Arterial Stiffness Parameters in Patients Undergoing Lower Limb Angiographic Procedure
by: Karl Kuusik, et al.
Published: (2020-02-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

NEBIVOLOL: HAEMODYNAMIC EFFECTS AND CLINICAL SIGNIFICANCE OF COMBINED BETA-BLOCKADE AND NITRIC OXIDE RELEASE
by: Otto Kamp, et al.
Published: (2010-08-01)

P4.05 CHARACTERISTICS OF AORTIC STIFFNESS IN DIABETIC RATS TREATED WITH VITAMIN D
by: E. Salum, et al.
Published: (2011-11-01)

Interaction of Palmitic Acid with Metoprolol Succinate at the Binding Sites of Bovine Serum Albumin
by: Mashiur Rahman, et al.
Published: (2014-12-01)

Atenolol’s Inferior Ability to Reduce Central vs Peripheral Blood Pressure Can Be Explained by the Combination of Its Heart Rate-Dependent and Heart Rate-Independent Effects
by: Tuuli Teeäär, et al.
Published: (2020-01-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

Measurements, Thermodynamic Modeling, and a Hydrogen Bonding Study on the Solubilities of Metoprolol Succinate in Organic Solvents
by: Jian Shen, et al.
Published: (2018-09-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Pharmacokinetics of Metoprolol in Chinese of Different CYP2D6
by: Chuang, Shu-kuei, et al.
Published: (1997)

P3.8 ACUTE EFFECTS OF CONTRAST MEDIA ON CENTRAL HEMODYNAMICS, ARTERIAL STIFFNESS, INFLAMMATORY AND KIDNEY INJURY BIOMARKERS
by: K. Paapstel, et al.
Published: (2014-11-01)

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)

Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug
by: Benjamin Berger, et al.
Published: (2018-07-01)

INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
by: V. G. Tregubov, et al.
Published: (2016-01-01)

Effects of Flos carthami on CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats
by: Gaofeng Liu, et al.
Published: (2011-01-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
by: Yoann Rousselin, et al.
Published: (2012-12-01)

Nebivolol for treatment patients with arterial hypertension
by: O M Mikheeva, et al.
Published: (2014-09-01)

NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER
by: T. Műnzel, et al.
Published: (2016-01-01)

EVALUATING THE CLINICAL AND HEMODYNAMICAL ACTION OF NEBIVOLOL IN CHRONIC HEART FAILURE
by: M. A. Gurevich, et al.
Published: (2001-04-01)